Cargando…

Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature

BACKGROUND: Strategies for screening and intervening to reduce the risk of cardiovascular disease (CVD) in primary care settings need to be assessed in terms of both their costs and long-term health effects. We undertook a literature review to investigate the methodologies used. METHODS: In a framew...

Descripción completa

Detalles Bibliográficos
Autores principales: Epstein, David, García-Mochón, Leticia, Kaptoge, Stephen, Thompson, Simon G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047941/
https://www.ncbi.nlm.nih.gov/pubmed/26682549
http://dx.doi.org/10.1007/s10198-015-0753-2
_version_ 1782457502374297600
author Epstein, David
García-Mochón, Leticia
Kaptoge, Stephen
Thompson, Simon G.
author_facet Epstein, David
García-Mochón, Leticia
Kaptoge, Stephen
Thompson, Simon G.
author_sort Epstein, David
collection PubMed
description BACKGROUND: Strategies for screening and intervening to reduce the risk of cardiovascular disease (CVD) in primary care settings need to be assessed in terms of both their costs and long-term health effects. We undertook a literature review to investigate the methodologies used. METHODS: In a framework of developing a new health-economic model for evaluating different screening strategies for primary prevention of CVD in Europe (EPIC-CVD project), we identified seven key modeling issues and reviewed papers published between 2000 and 2013 to assess how they were addressed. RESULTS: We found 13 relevant health-economic modeling studies of screening to prevent CVD in primary care. The models varied in their degree of complexity, with between two and 33 health states. Programmes that screen the whole population by a fixed cut-off (e.g., predicted 10-year CVD risk >20 %) identify predominantly elderly people, who may not be those most likely to benefit from long-term treatment. Uncertainty and model validation were generally poorly addressed. Few studies considered the disutility of taking drugs in otherwise healthy individuals or the budget impact of the programme. CONCLUSIONS: Model validation, incorporation of parameter uncertainty, and sensitivity analyses for assumptions made are all important components of model building and reporting, and deserve more attention. Complex models may not necessarily give more accurate predictions. Availability of a large enough source dataset to reliably estimate all relevant input parameters is crucial for achieving credible results. Decision criteria should consider budget impact and the medicalization of the population as well as cost-effectiveness thresholds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10198-015-0753-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5047941
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-50479412016-10-18 Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature Epstein, David García-Mochón, Leticia Kaptoge, Stephen Thompson, Simon G. Eur J Health Econ Original Paper BACKGROUND: Strategies for screening and intervening to reduce the risk of cardiovascular disease (CVD) in primary care settings need to be assessed in terms of both their costs and long-term health effects. We undertook a literature review to investigate the methodologies used. METHODS: In a framework of developing a new health-economic model for evaluating different screening strategies for primary prevention of CVD in Europe (EPIC-CVD project), we identified seven key modeling issues and reviewed papers published between 2000 and 2013 to assess how they were addressed. RESULTS: We found 13 relevant health-economic modeling studies of screening to prevent CVD in primary care. The models varied in their degree of complexity, with between two and 33 health states. Programmes that screen the whole population by a fixed cut-off (e.g., predicted 10-year CVD risk >20 %) identify predominantly elderly people, who may not be those most likely to benefit from long-term treatment. Uncertainty and model validation were generally poorly addressed. Few studies considered the disutility of taking drugs in otherwise healthy individuals or the budget impact of the programme. CONCLUSIONS: Model validation, incorporation of parameter uncertainty, and sensitivity analyses for assumptions made are all important components of model building and reporting, and deserve more attention. Complex models may not necessarily give more accurate predictions. Availability of a large enough source dataset to reliably estimate all relevant input parameters is crucial for achieving credible results. Decision criteria should consider budget impact and the medicalization of the population as well as cost-effectiveness thresholds. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10198-015-0753-2) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-12-18 2016 /pmc/articles/PMC5047941/ /pubmed/26682549 http://dx.doi.org/10.1007/s10198-015-0753-2 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Epstein, David
García-Mochón, Leticia
Kaptoge, Stephen
Thompson, Simon G.
Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title_full Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title_fullStr Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title_full_unstemmed Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title_short Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
title_sort modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047941/
https://www.ncbi.nlm.nih.gov/pubmed/26682549
http://dx.doi.org/10.1007/s10198-015-0753-2
work_keys_str_mv AT epsteindavid modelingthecostsandlongtermhealthbenefitsofscreeningthegeneralpopulationforrisksofcardiovasculardiseaseareviewofmethodsusedintheliterature
AT garciamochonleticia modelingthecostsandlongtermhealthbenefitsofscreeningthegeneralpopulationforrisksofcardiovasculardiseaseareviewofmethodsusedintheliterature
AT kaptogestephen modelingthecostsandlongtermhealthbenefitsofscreeningthegeneralpopulationforrisksofcardiovasculardiseaseareviewofmethodsusedintheliterature
AT thompsonsimong modelingthecostsandlongtermhealthbenefitsofscreeningthegeneralpopulationforrisksofcardiovasculardiseaseareviewofmethodsusedintheliterature